BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $3.34M invested in ProShares UltraShort NASDAQ Biotechnology in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.29M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$655K
2
+$478K
3
+$363K
4
TRCT
Tower Research Capital (TRC)
New York
+$183K
5
Morgan Stanley
Morgan Stanley
New York
+$98K

Top Sellers

1
-$961K
2
-$429K
3
-$21.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$787K
2
$769K
3
$655K
4
$478K
5
$212K
6
$186K
7
$108K
8
$102K
9
$28K
10
$7K
11
$5K